USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
US Autoimmune Disease Diagnostics Market, Forecast to 2020
Systemic Autoimmune Diseases to Spur Double-digit Market Growth as Participants Look to Unmet Needs and Game-changing Strategies to Boost Revenues
24-Feb-2016
North America
Market Research
9AB9-00-48-00-00
HC02380-NA-MR_16502
According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as well as localized diseases, such as celiac, IBD, IBS, and Hashimoto's. Systemic diseases dominate the market due to their high prevalence in the United States and also because of the market participation of large diagnostics companies, such as Inova Diagnostics, Siemens Healthcare, Abbott Diagnostics, and Beckman Coulter. The localized disease segment is the fastest-growing, mainly due to celiac, as gluten intolerance in the United States is increasing at an exponential rate.
Scope and Segmentation
Key Predictions: US Autoimmune Disease Diagnostics Market
Current Trends in the Autoimmune Disease Diagnostics Market
Autoimmune Disease Diagnostics Market—Overview
Key Companies to Watch
Ecosystem of the Autoimmune Disease Diagnostics Market
Significance of the Autoimmune Disease Diagnostics Market
Significance of the Autoimmune Disease Diagnostics Market—Prevalence Rates
Competitive Landscape
Key Diseases and Available Solutions in the US Market
Key Diseases and Available Solutions in the US Market (continued)
LDTs—Role in Autoimmune Disease Diagnostics
Segment Lifecycle Analysis by Disease
Overall Market Forecast
Overall Disease Segment Share
Competitive SWOT Analysis by Company
Competitive SWOT Analysis by Company (continued)
Where do the Opportunities Lie in this Market?
Pharma and Diagnostics Business Integration
Autoimmune Diagnostics Companies are Uniting with Pharmaceuticals to Diversify Revenue Channels
Direct-to-Consumer Market: The Risk and The Opportunity
Localized Disease Diagnostics Segment Revenue
Growth Rate by Localized Autoimmune Diseases
Competitive Value Matrix—Localized Disease Diagnostics Segment
Autoimmune Tests—Role in Patient Continuum
Systemic Disease Diagnostics Segment Revenue
Growth Rate by Systemic Autoimmune Diseases
Competitive Value Matrix—Systemic Disease Diagnostics Segment
Autoimmune Tests—Role in Patient Continuum
Key Conclusions and Future Outlook
Legal Disclaimer
Celiac Disease-specific LDT Assays
Chron’s Disease-specific LDT Assays
RA-specific LDT Assays
Lupus-specific LDT Assays
IBD/IBS-specific LDT Assays
Others
Learn More—Next Steps
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
15 Oct 2026 | Global | Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...
08 Oct 2026 | Global | Frost Radar
Frost Radar: Endoscopy Device Technology Ecosystem, 2026
The endoscopy device market is advancing toward higher-quality visualization and improved clinical decision-making, with innovation across 4K ultrahigh-definition display systems, image-enhanced endoscopy, and computer-aided detection systems. Advanced visualization is evolving through improvements ...
07 Oct 2026 | Global | Technology Research
Growth Opportunities in Image-Guided Cancer Ablation Systems
Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.